BioNxt (BNXT.C) rips as European Patent Office backs Cladribine thin-film
BioNxt Solutions (CSE: BNXT) received a share price boost today after announcing the European Patent Office and its Eurasian counterpart have waved through core claims tied to the company’s sublingual…
Read More